| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 36,174 | 38,289 | 36,087 | 46,259 | | Cost of Revenue | 25,754 | 26,839 | 30,066 | 31,886 | | | Gross Profit | 10,420 | 11,450 | 6,021 | 14,373 | | | Operating Expenses | | Research Development | 3,071 | 2,911 | 3,529 | 3,862 | | Selling General and Administrative | 8,959 | 8,291 | 8,570 | 9,191 | | Non Recurring |
-
|
-
| 9,724 | 681 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 7,656 | 248 | (15,802) | 639 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 9,090 | (61) | (301) | 858 | | Earnings Before Interest And Taxes | 5,765 | 187 | (16,103) | 1,497 | | Interest Expense |
-
| 617 | 438 | 557 | | Income Before Tax | 5,765 | (430) | (16,541) | 940 | | Income Tax Expense | 1,867 | (393) | (3,094) | 477 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,898 | (37) | (13,447) | 463 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,898 | (37) | (13,447) | 463 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,898 | ($37) | ($13,447) | $463 |
|
0.03% Nasdaq 
Income Statement
